-

Medisca Opens New Pharmaceutical Repackaging Facility to Meet Global Demands in Personalized Medicine

PLATTSBURGH, N.Y.--(BUSINESS WIRE)--Medisca, a global leader in personalized pharmaceutical solutions, held a grand opening event on June 20, 2024, for their new repackaging and distribution facility in Plattsburgh, New York. The event was celebrated in the company of Medisca’s valued Plattsburgh team, business partners, and state and federal officials, including Congresswoman Elise Stefanik, Senator Dan Stec, and Assemblyman Billy Jones.

"This event marks the completion of the largest project ever undertaken by Medisca in our 35-year history," said Antonio Dos Santos, Medisca Founder and Chairman. “This new facility showcases the diligent efforts and dedication of Medisca people and demonstrates our commitment to supporting the growing demands in personalized medicine."

Continued investment in the North Country

After 32 years of established standing and investment in the North Country, the opening of the new Medisca facility in Plattsburgh exemplifies the value of the workforce in this region.

"The new Medisca facility is a testament to our local workforce talent pool, already providing 65 good-paying local jobs with plans for further expansion," said Congresswoman Elise Stefanik. "This significant investment in Plattsburgh underscores the strength of our region. I am proud to support Medisca and the many industries investing in our community and driving economic prosperity for hardworking families in Upstate and the North Country."

Doubling capacity to serve the growing demands in personalized medicine

Consolidating existing operations into a single site equipped with innovative machinery and automated workflows, the new facility will significantly enhance the company’s capacity to support the diverse healthcare groups it serves.

“In particular, the new facility will allow Medisca to expand its capacity to provide quality products to pharmacists and healthcare professionals, so they can prepare personalized and essential medications for patients like you and me – not just here in the United States, but across the globe,” said Sanjay Goorachurn, Medisca CEO.

Leveraging scalable innovation, reinforcing established quality systems, and prioritizing the health, safety, and wellness of Medisca personnel were paramount in every decision made during the design and construction of the new facility. Key considerations included introducing custom-tailored ISO-rated production rooms and leveraging customized warehouse management systems for end-to-end traceability.

“Taken together, the new facility is a state-of-the-art example that leverages innovation and rigorous quality and safety measures to protect our product, personnel, and environment,” said Dos Santos.

The new Medisca Plattsburgh facility has undergone a successful New York State inspection and third-party documentation and systems audit, with additional licensures and agency inspections actively underway to serve the United States and Global markets. For a look at the new facility, click here.

About Medisca

Founded in 1989, Medisca is a global leader in personalized medicine and pharmaceutical supply chain solutions. Its vast portfolio of over 2,000 products is complemented by a library of 10,000+ proprietary and customized medication formulas, expertise, and services in pharmaceutical compounding, continuing healthcare education, analytical testing, and more. Providing finely-tuned solutions to diverse wellness sectors across the globe, Medisca is bridging the gaps in healthcare and empowering personalized wellness for all. For more information, visit www.medisca.com and follow us on LinkedIn, Facebook, and YouTube.

Contacts

Medisca Communications
communications@medisca.com
1-800-665-6334

More News From Medisca

Medisca Statement on Settlement With Department of Justice

PLATTSBURGH, N.Y.--(BUSINESS WIRE)--Medisca Inc. has reached an agreement with the United States Department of Justice (DOJ) to resolve and terminate a civil investigation that began 9 years ago. The allegations made by the DOJ relate to the accuracy of the company’s disclosure of average wholesale prices (AWPs) for certain pharmaceutical ingredients from January 2012 to May 2015, and the reimbursement by the TRICARE program of pharmacies that purchased these ingredients at a price lower than t...

A new chapter for Medisca: Sanjay D. Goorachurn appointed as Chief Executive Officer

MONTREAL--(BUSINESS WIRE)--Medisca, a global company specializing in personalized pharmaceutical solutions, is pleased to announce the appointment of Sanjay D. Goorachurn as the company’s new CEO, as founders, Tony Dos Santos and Maria Zaccardo, transition into strategic advisory roles as Chair and Vice Chair, respectively. Coinciding with the company’s 35th anniversary, this decision marks a significant milestone in Medisca’s history. In 1989, Medisca opened its doors as a team of three with t...

Medisca Opens MAZ® Lab in Arizona: An Innovation and Customer Resource Center

PLATTSBURGH, N.Y.--(BUSINESS WIRE)--Medisca, a global leader in personalized medicine and pharmaceutical supply chain solutions, proudly announces the opening of the Medisca MAZ Lab in Phoenix, Arizona. Dedicated exclusively to the development and expansion of the MAZ ecosystem, the MAZ Lab is an innovation and customer resource center. Introduced in 2016 as the first planetary mixer to enter the pharmaceutical compounding market and now making its mark in cannabis and other wellness industries...
Back to Newsroom